Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a 13C Glucose Breath Test to Quantify Insulin Resistance in Type 1 Diabetes Mellitus Compared With the Euglycaemic Clamp Test

NCT04623320 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT04623320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04623320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a 13C Glucose Breath Test to Quantify Insulin Resistance in Type 1 Diabetes Mellitus Compared With the Euglycaemic Clamp Test
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Unknown status
Start date
October 27, 2020
Completion date
March 31, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, type 1 diabetes